Dermatol. praxi. 2018;12(1):43-46 | DOI: 10.36290/der.2018.036

Over-the-counter drugs against hair loss

Mgr. Markéta Peřinová
Lékárna Aspasia, Milevsko

Hair loss is one of the frequent reasons why patients come to the pharmacy and try to solve their problems by self-treatment.This paper offers an overview of over-the-counter drugs and medicinal substances against hair loss which exist either in oral ortopical route of administration. Although a wide range of products is available at the market only a few of them include registereddrugs. They are usually food supplements and cosmetic products. Most medical substances lack the proof of efficiency. The onlyexception is minoxidil but its effect disappears after 3 to 4 months from the end of the application. Other used substances includecaffeine, vitamins, minerals and other nutrition factors as well as extracts from medicinal herbs. Particular attention needs to bepaid to pregnant and breast-feeding women – the best choice are products designed especially for them.

Keywords: over-the-counter drugs, hair loss, minoxidil, caffeine

Received: February 22, 2017; Accepted: March 29, 2017; Published: March 22, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Peřinová M. Over-the-counter drugs against hair loss. Dermatol. praxi. 2018;12(1):43-46. doi: 10.36290/der.2018.036.
Download citation

References

  1. Alušík Š. Klinické projevy nežádoucích účinků léků. Praha: Triton 2001.
  2. Dinh QQ, Sinclair R. Female pattern hair loss: Current treatment concepts. Clinical Interventions in Aging 2007.
  3. Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. Journal of the American Academy of Dermatology 2008; 59(4): 547-566. Go to original source...
  4. Price VH. Treatment of hair loss. New England Journal of Medicine 1999; 341(13): 964-973. Go to original source...
  5. Lincová D, Farghali H. Základní a aplikovaná farmakologie. 2., dopl. a přeprac. vyd. Praha: Galén 2007.
  6. Databáze léků. Státní ústav pro kontrolu léčiv [online]. Praha [cit. 2017-01-03]. Dostupné z: http://www.sukl.cz/modules/medication/search.php.
  7. Otberg N, et al. The role of hair follicles in the percutaneous absorption of caffeine. British journal of clinical pharmacology 2008; 65(4): 488-492. Go to original source...
  8. Otberg N, et al. Follicular penetration of topically applied caffeine via a shampoo formulation. Skin pharmacology and physiology 2007; 20(4): 195-198. Go to original source... Go to PubMed...
  9. Fischer TW, Hipler UC, Elsner P. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. International journal of dermatology 2007; 46(1): 27-35. Go to original source...
  10. Blumeyer A, et al. Evidence - based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2011; 9(s6): S1-S57. Go to original source...
  11. Kučerová R, Bienová M. Current therapies of female androgenetic alopecia and use of fluridil, a novel topical antiandrogen. Scripta Medica (Brno) 2006; 79(1): 35-48.
  12. Blume-Peytavi U, et al. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. Journal of the American Academy of Dermatology 2012; 66(5): 794-800. Go to original source... Go to PubMed...
  13. Tsuboi R, et al. Guidelines for the management of androgenetic alopecia (2010). The Journal of dermatology 2012; 39(2): 113-120. Go to original source... Go to PubMed...
  14. Rushton DH. Nutritional factors and hair loss. Clinical and experimental dermatology 2002; 27(5): 396-404. Go to original source... Go to PubMed...
  15. Draelos ZD, et al. A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia. Journal of cosmetic dermatology 2005; 4(4): 258-261. Go to original source... Go to PubMed...
  16. Lengg N, et al. Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial. Therapy 2007; 4(1): 59-65. Go to original source...
  17. Rushton DH. Nutritional factors and hair loss. Clinical and experimental dermatology 2002; 27(5): 396-404. Go to original source... Go to PubMed...
  18. Jahodář L. Léčivé rostliny v současné medicíně: (co Mattioli ještě nevěděl). Praha: Havlíček Brain Team 2010..
  19. Agrawal KK, et al. Alopecia switch to herbal medicine. Journal od pharmaceutical research & opinion 2014; 1.4.
  20. Cho YH, et al. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial. Evidence-based complementary and alternative medicine 2014. Go to original source...
  21. Shao L-X. Effects of the extract from bergamot and boxthorn on the delay of skin aging and hair growth in mice. China journal of Chinese materia medica 2003; 28(8): 766-769.
  22. Murkute AV, et al. Development and evaluation of formulations of microbial biotransformed extract of tobacco leaves for hair growth potential. Pharmacognosy research 2010; 2(5): 300. Go to original source... Go to PubMed...
  23. Hay IC Jamieson M, Ormerod AD. Randomized trial of aromatherapy: successful treatment for alopecia areata. Archives of dermatology 1998; 134(11): 1349-1352. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.